Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone hydroxyapatite is the primary mineral component of bone, providing structural support and serving as a reservoir for calcium and phosphate ions. It undergoes dynamic remodeling in response to physiological and pathological stimuli. In diseases like osteoporosis and bone metastasis, the normal deposition and resorption of hydroxyapatite are disrupted, leading to altered bone structure and function. It is a target for diagnostic imaging and therapeutic interventions like bisphosphonates, which bind to hydroxyapatite to inhibit osteoclast activity.
Bisphosphonates bind to hydroxyapatite, inhibiting osteoclast activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Hydroxyapatite (HA).